G. Wei Xu
- Co-authors
- Sirano Dhe‐PaganonAaron D. SchimmerRose HurrenMohsin AliNeil MacLeanJohn C. ReedDavid R. RoseTroy Ketela
- Topics
- Ubiquitin and proteasome pathways (6 papers)Protein Degradation and Inhibitors (5 papers)RNA modifications and cancer (2 papers)
- Cited by
- Molecular BiologyOncologyHematology
- Journals
- CirculationBloodPLoS ONE
- Partner nations
- CanadaChinaUnited States
In The Last Decade
G. Wei Xu
10 papers receiving 249 citations
Peers
Comparison fields: 5 of 42
- Molecular Biology 218
- Oncology 79
- Cancer Research 31
- Epidemiology 29
- Hematology 25
Countries citing papers authored by G. Wei Xu
This map shows the geographic impact of G. Wei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Wei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Wei Xu more than expected).
Fields of papers citing papers by G. Wei Xu
This network shows the impact of papers produced by G. Wei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Wei Xu. The network helps show where G. Wei Xu may publish in the future.
Co-authorship network of co-authors of G. Wei Xu
This figure shows the co-authorship network connecting the top 25 collaborators of G. Wei Xu. A scholar is included among the top collaborators of G. Wei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Wei Xu. G. Wei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 5 | |
| 3 | 0 | |
| 4 | 14 | |
| 5 | 1 | |
| 6 | 7 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | 0 | |
| 10 | 33 | |
| 11 | 6 | |
| 12 | 37 | |
| 13 | 132 |
About G. Wei Xu
G. Wei Xu is a scholar working on Cancer Research, Hematology and Molecular Biology, having authored 13 papers that have together received 252 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Protein Degradation and Inhibitors (5 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Molecular Biology (218 citations), Oncology (79 citations) and Hematology (25 citations). G. Wei Xu has collaborated with scholars based in Canada, China and United States. Frequent co-authors include Sirano Dhe‐Paganon, Aaron D. Schimmer, Rose Hurren, Mohsin Ali, Neil MacLean, John C. Reed, David R. Rose, Troy Ketela, Xinliang Mao and Reza Beheshti Zavareh. Their work appears in journals such as Circulation, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.